openPR Logo
Press release

Anticoagulant Rodenticides Market Is Projected To Reach A Valuation Of US$ 1.4 Bn By 2032

06-16-2022 10:46 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Fact.MR

The global Anticoagulant rodenticides Market is estimated at US$ 720.4 Mn in 2022 and is projected to reach a valuation of US$ 1.4 Bn by 2032, expanding at a CAGR of 3.3% through the forecast period of 2022-2032.

Anticoagulant rodenticides find their application in a multitude of industries including agriculture, metropolitan centres, and residences, as well as pest control firms and warehouses. Over the projected period, the market for anticoagulant rodenticides is predicted to rise due to growing demand for rodenticides to reduce the rodent population. During the projected period, increased demand for rodent control, the prevalence of rodent-related illnesses, an increase in rat population, and the availability of natural rodent control solutions are expected to drive market growth globally.

To remain 'ahead' of your competitors, request for a sample - https://www.factmr.com/connectus/sample?flag=S&rep_id=7249

The report offers actionable and valuable market insights of Anticoagulant Rodenticides. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Anticoagulant Rodenticides across various industries and regions.

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Anticoagulant Rodenticides. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Anticoagulant Rodenticides

This newly published and insightful report sheds light on Market Insights of Anticoagulant Rodenticides, key dynamics, their impact on the overall value chain from suppliers to end-users and Growth of Anticoagulant Rodenticides.

Key Companies Profiled
• BASF SE
• Bayer
• Syngenta
• UPL
• Liphatech Inc.
• JT Eaton
• Neogen Corporation
• Pelgar International
• Senestech Inc.
• Bell Laboratories
• Impex Europa
• Rentokil Initial Plc
• Terminix
• Ecolab

Need more information about Report Methodology? Click here- https://www.factmr.com/connectus/sample?flag=S&rep_id=7249

Key Segments Covered in Anticoagulant Rodenticides Industry Survey
Product Type Outlook
• 1st Generation Anticoagulants
• 2nd Generation Anticoagulants

Form Outlook
• Pellets
• Blocks
• Powders & Sprays

Application Outlook
• Agriculture
• Pest Control Companies
• Warehouses
• Urban Centers
• Household
• Others

Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/7249

Which type of Anticoagulant Rodenticides is set to Garner High Share?
Second-generation anticoagulant rodenticides are longer to break down than first-generation anticoagulant rodenticides, and therefore represent a larger risk of secondary poisoning in non-target animals. Because of their decreased toxicity compared to 2nd generation anticoagulant rodenticides, demand for 1st generation anticoagulant rodenticides is predicted to rise throughout the forecast period.

In Australia, three active ingredients of first-generation anticoagulant rodenticides have been approved for usage. The Australian Pesticides and Veterinary Medicines Authority has approved and accepted diphacinone, coumatetralyl, and warfarin for use near industrial, agricultural, commercial, and residential structures. Coumatetralyl is permitted for use on crops, however only in covered bait stations as part of a comprehensive rodent control programme.

Explore Fact.MR's Coverage on the Chemicals and Materials Domain:

Bio-succinic Acid Market - https://www.factmr.com/report/5405/biosuccinic-acid-market

Surge Suppression IC Market - https://www.factmr.com/report/surge-suppression-ic-market

Liquid Propellants Market - https://www.factmr.com/report/Liquid-Propellants-Market

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

About US

Market research and consulting agency with a difference! That's why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range - from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we'll be an able research partner.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anticoagulant Rodenticides Market Is Projected To Reach A Valuation Of US$ 1.4 Bn By 2032 here

News-ID: 2655178 • Views:

More Releases from Fact.MR

Craft Beer Market is forecasted to reach a value of US$ 174.68 Billion by 2032
04-24-2024 | Food & Beverage
Fact.MR
Craft Beer Market is forecasted to reach a value of US$ 174.68 Billion by 2032
The worldwide craft beer market was expected to be worth $76.3 billion in 2020 and $81.64 billion in 2021. The market will grow at a steady CAGR of 6.9% between 2022 and 2032. By the end of 2032, this market is predicted to have a global valuation of US$174.68 billion. The surge in demand for more beer styles coupled with increase in per capita income among the target customers has triggered
Window Blinds Market Forecasted to Achieve US$ 4.69 Billion by 2034
Window Blinds Market Forecasted to Achieve US$ 4.69 Billion by 2034
The global window blinds market is expected to reach $2.99 billion in 2024, growing at a 5.8% CAGR to $4.69 billion by the end of 2034. Window blinds are adjustable window coverings made of slats or vanes, allowing for versatile control over light and privacy. They come in various materials, including wood, metal, or plastic, and can be easily adjusted to regulate sunlight and maintain privacy. Unlike heavy curtains, blinds are
Vacuum Salt Market is Expected to reach 12,765.2 Million by 2034
04-24-2024 | Food & Beverage
Fact.MR
Vacuum Salt Market is Expected to reach 12,765.2 Million by 2034
The global vacuum salt market is expected to be worth US$ 8,012.3 million in 2024. Projections show a steady expansion with a 4.8% CAGR through 2034. The market is anticipated to be valued at $12,765.2 million by 2034. Growing consumer preference for the ingredient's use in the production of food, as vacuum salt is essential to create a balanced diet, is the factor driving the growth of the global market. The
Hemoglobinopathy Market Forecast Growing at 8.3% CAGR to Reach $1.7 Billion by 2034
04-24-2024 | Health & Medicine
Fact.MR
Hemoglobinopathy Market Forecast Growing at 8.3% CAGR to Reach $1.7 Billion by 2 …
In 2024, the global hemoglobinopathy market (ヘモグロビン症市場) is estimated to be worth US$788.1 million, with a projected compound annual growth rate (CAGR) of 8.3% through 2034. By 2034, the market size is expected to exceed US$1,745.7 million. The rise of genetic testing has led to a significant shift in the hemoglobinopathy market towards personalized medication. Companies are leveraging this trend to develop tailored treatment plans based on each patient's DNA

All 5 Releases


More Releases for Anticoagulant

Anticoagulant Treatment Market 2021 | Detailed Report
The Anticoagulant Treatment market research report delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. The Anticoagulant Treatment report also incorporates the current and future global market outlook in the emerging and developed markets. Moreover, the report also investigates regions/countries expected to witness the fastest growth rates during the forecast period. Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4988667 The Anticoagulant Treatment research report also provides
Anticoagulant Reversal Medicine Market global outlook and forecast 2021 -2027
The Global Anticoagulant Reversal Medicine Market research report is a careful examination of the worldwide industry which has been a region of enthusiasm for a Anticoagulant Reversal Medicine makers, organizations, authorities, chiefs, and likely speculators, and analysts. The report profoundly lights up noteworthy features in the business, including a contention situation, condition, portions, showcase size, share, gainfulness, development potential, and advancements. The report likewise
Anticoagulants Market To See Record Break Revenue $43.42 Million By 2025 | Vitam …
Anticoagulants are medicinal substances that reduce the coagulation of blood and prolong the clotting time. Anticoagulant drugs achieve their effects by suppressing the synthesis or function of various clotting factors that exist in the blood. The global anticoagulants market is anticipated to show significant market growth during the forecast period, owing to increase in prevalence of ischemic heart disease and venous thromboembolism (VTE) and awareness of novel oral anticoagulants (NOACs).
Anticoagulant Drugs Market Size, Share, Development by 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global Anticoagulant Drugs market. Click to view the full report TOC, figure and tables: https://www.marketresearchreportstore.com/reports/241687/global-anticoagulant-drugs-market Global Anticoagulant Drugs Market: Forecast by Type / Application / Region Anticoagulant drugs (also known as blood thinners) are chemical substances that prevent or reduce coagulation of blood and prolong the blood clotting time. According to this study, over the next five years the Anticoagulant Drugs
Global Antithrombotic/Anticoagulant Drugs Technologies and Market Research Repor …
Researchmoz added Most up-to-date research on "Antithrombotic/Anticoagulant Drugs: Technologies and Global Markets" to its huge collection of research reports. The global market for antithrombotic/anticoagulant drugs should reach $27.3 billion by 2021 from $18.9 billion in 2016, a compound annual growth rate (CAGR) of 7.6%, from 2016 to 2021. The North American antithrombotic/anticoagulant drugs market is expected to grow from nearly $8.0 billion in 2016 to nearly $11.0 billion in 2021, a CAGR
Global Heparin Anticoagulant Market $11.5 Billion by 2021
The global heparin anticoagulant market is estimated to reach $11.5 Billion in 2021, growing at a CAGR of 4.4% from 2017 to 2021, according to a market research report Heparin Anticoagulant Market Analysis and Forecast 2017-2021, published by iHealthcareAnalyst, Inc. The global heparin anticoagulant market report provides market size (Revenue $Million 2014 to 2021), market share, market trends and forecasts growth trends (CAGR%, 2017 to 2021). The global heparin anticoagulant market